Total Payments
$53,326
2024 Payments
$607.42
Companies
49
Transactions
336
Medicare Patients
1,680
Medicare Billing
$146,367
Payment Breakdown by Category
Other$36,135 (67.8%)
Travel$7,161 (13.4%)
Food & Beverage$5,729 (10.7%)
Consulting$3,475 (6.5%)
Education$825.65 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $36,135 | 19 | 67.8% |
| Travel and Lodging | $7,161 | 17 | 13.4% |
| Food and Beverage | $5,729 | 288 | 10.7% |
| Consulting Fee | $3,475 | 2 | 6.5% |
| Education | $825.65 | 10 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Seagen Inc. | $24,877 | 23 | $0 (2022) |
| Astellas Pharma US Inc | $16,837 | 34 | $0 (2023) |
| AMAG Pharmaceuticals, Inc. | $3,137 | 3 | $0 (2017) |
| Janssen Biotech, Inc. | $2,176 | 10 | $0 (2024) |
| Celgene Corporation | $1,802 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $572.93 | 39 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $445.24 | 37 | $0 (2024) |
| Incyte Corporation | $303.36 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $293.27 | 12 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $256.89 | 18 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $607.42 | 31 | Incyte Corporation ($114.97) |
| 2023 | $606.17 | 29 | Incyte Corporation ($108.00) |
| 2022 | $4,601 | 27 | Seagen Inc. ($4,201) |
| 2021 | $18,251 | 27 | Seagen Inc. ($17,893) |
| 2020 | $3,366 | 29 | Seagen Inc. ($2,783) |
| 2019 | $10,004 | 55 | Astellas Pharma US Inc ($9,243) |
| 2018 | $10,230 | 86 | Astellas Pharma US Inc ($7,264) |
| 2017 | $5,660 | 52 | AMAG Pharmaceuticals, Inc. ($3,137) |
All Payment Transactions
336 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Oncology | ||||||
| 11/27/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Oncology | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $20.25 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: HEMATOLOGY | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.00 | General |
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $18.42 | General |
| Category: Oncology | ||||||
| 10/16/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: ONCOLOGY | ||||||
| 10/14/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Oncology | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $14.80 | General |
| Category: Hematology/Oncology | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Oncology | ||||||
| 09/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.10 | General |
| 08/20/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: ONCOLOGY | ||||||
| 07/31/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $16.74 | General |
| 07/30/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $15.18 | General |
| Category: Hematology/Oncology | ||||||
| 06/27/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Oncology | ||||||
| 06/20/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $16.80 | General |
| 06/11/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Oncology | ||||||
| 05/16/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $17.27 | General |
| Category: Oncology | ||||||
| 05/13/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Oncology | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Oncology | ||||||
| 05/07/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $16.90 | General |
| Category: Hematology | ||||||
| 05/07/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 251 | 553 | $51,061 | $19,759 |
| 2022 | 7 | 350 | 904 | $62,641 | $31,717 |
| 2021 | 9 | 448 | 1,310 | $87,251 | $44,979 |
| 2020 | 13 | 631 | 1,504 | $106,106 | $49,913 |
Total Patients
1,680
Total Services
4,271
Medicare Billing
$146,367
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 114 | $32,649 | $11,723 | 35.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 28 | $10,991 | $4,075 | 37.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 82 | 202 | $1,603 | $1,537 | 95.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 78 | 191 | $3,047 | $1,454 | 47.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 13 | 18 | $2,771 | $970.08 | 35.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 169 | $34,157 | $17,476 | 51.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 35 | $9,807 | $5,532 | 56.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 46 | $6,417 | $3,490 | 54.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 96 | 270 | $3,870 | $2,043 | 52.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 12 | 19 | $2,470 | $1,193 | 48.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 18 | 90 | $4,050 | $1,171 | 28.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 95 | 275 | $1,870 | $812.03 | 43.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 102 | 211 | $37,980 | $21,631 | 57.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 84 | $10,500 | $6,365 | 60.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 33 | 37 | $8,991 | $5,542 | 61.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 14 | 52 | $6,760 | $2,697 | 39.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 112 | 365 | $7,300 | $2,680 | 36.7% |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2021 | 13 | 79 | $3,950 | $2,162 | 54.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 15 | 128 | $5,760 | $1,599 | 27.8% |
| 99358 | Prolonged patient service without direct patient contact first hour | Office | 2021 | 13 | 13 | $2,600 | $1,279 | 49.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 111 | 341 | $3,410 | $1,023 | 30.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 94 | 197 | $35,460 | $17,201 | 48.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 79 | 175 | $21,875 | $11,063 | 50.6% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 17 | 56 | $14,000 | $6,738 | 48.1% |
| 99354 | Prolonged office or other outpatient service first hour | Office | 2020 | 27 | 27 | $6,075 | $3,056 | 50.3% |
About Dr. James Orsini, MD
Dr. James Orsini, MD is a Hematology & Oncology healthcare provider based in Belleville, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1922084185.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Orsini, MD has received a total of $53,326 in payments from pharmaceutical and medical device companies, with $607.42 received in 2024. These payments were reported across 336 transactions from 49 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($36,135).
As a Medicare-enrolled provider, Orsini has provided services to 1,680 Medicare beneficiaries, totaling 4,271 services with total Medicare billing of $146,367. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Belleville, NJ
- Active Since 12/20/2005
- Last Updated 02/28/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1922084185
Products in Payments
- PADCEV (Biological) $24,873
- XTANDI (Drug) $8,300
- FERAHEME (Drug) $3,137
- Erleada (Drug) $1,990
- Abraxane (Drug) $1,728
- KISQALI (Drug) $303.64
- TAGRISSO (Drug) $224.81
- ELIQUIS (Drug) $159.76
- Xofigo (Drug) $148.13
- OPDIVO (Biological) $141.49
- UroLift (Device) $122.03
- PROVENGE (Drug) $112.35
- JAKAFI (Drug) $111.48
- Lenvima (Drug) $107.97
- XPOVIO (Drug) $102.29
- BRUKINSA (Drug) $102.18
- Lupron (Drug) $99.00
- ERLEADA (Drug) $94.97
- LYNPARZA (Drug) $93.12
- DARZALEX (Biological) $91.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Belleville
Said Saleh, Md, MD
Hematology & Oncology — Payments: $55,405
Hematology & Oncology $55,405
John Conti, Md, MD
Hematology & Oncology — Payments: $10,557
Hematology & Oncology $10,557
Hemalatha Vasireddy, Md, MD
Hematology & Oncology — Payments: $8,097
Hematology & Oncology $8,097
Mrs. Sitamahalakshmi Yerramalli, Md, MD
Hematology & Oncology — Payments: $5,970
Hematology & Oncology $5,970
Alan Lippman, M.d, M.D
Hematology & Oncology — Payments: $828.57
Hematology & Oncology $828.57